Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions. (Q44401517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Francesco Frassoni

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Raiola AM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Van Lint MT

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Valbonesi M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Lamparelli T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gualandi F

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Occhini D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Bregante S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

di Grazia C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Dominietto A

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Soracco M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Vassallo F

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Casini M

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Bruno B

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Bacigalupo A

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

687-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692609%20AND%20SRC:MED&resulttype=core&format=json

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

Extramedullary relapse in the so-called 'sanctuary' sites for chemotherapy after donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703883

7 January 2021